These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21122296)

  • 1. [Expression of hepatoma-derived growth factor and its clinical implication in stage I non-small cell lung cancer].
    Zhou S; Xu S; Zhang H; Liu Z; Liang Z; Song X; Jiang Y; Zhao D
    Zhongguo Fei Ai Za Zhi; 2007 Aug; 10(4):291-5. PubMed ID: 21122296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of HDGF and its implication in stage I non-small cell lung cancer].
    Zhou SJ; Xu SF; Zhang HQ; Liu ZD
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):927-30. PubMed ID: 18478933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
    Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
    J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
    Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
    Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
    Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of caspase-3,survivin and k-ras in non-small cell lung cancer.].
    Li C; Hu B; Wang X; Ji C; He Y
    Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):90-6. PubMed ID: 20727274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.
    Lin YW; Li CF; Chen HY; Yen CY; Lin LC; Huang CC; Huang HY; Wu PC; Chen CH; Chen SC; Tai MH
    Oral Oncol; 2012 Jul; 48(7):629-35. PubMed ID: 22361040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M
    Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
    Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of angiogenesis and blood vessel invasion in stage I non-small cell lung cancer after complete surgical resection].
    Zhou S; Xu S; Zhang H; Liu Z; Liang Z; Song X; Jiang Y; Zhao D
    Zhongguo Fei Ai Za Zhi; 2007 Feb; 10(1):29-33. PubMed ID: 21110929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and clinical evaluation of a multi-purpose mAb and a sandwich ELISA test for hepatoma-derived growth factor in lung cancer patients.
    Zhang A; Long W; Guo Z; Liu G; Hu Z; Huang Y; Li Y; Grabinski TM; Yang J; Zhao PX; Everett AD; Zhang Y; Cao BB
    J Immunol Methods; 2010 Apr; 355(1-2):61-7. PubMed ID: 20193688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of vascular endothelial growth factor in human non-small cell lung cancer].
    Li B; Cao X; Zhang J; Jiang J; Yang Y; Gou Y
    Zhongguo Fei Ai Za Zhi; 2004 Apr; 7(2):142-5. PubMed ID: 21215010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
    Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
    Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
    Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.